Artisan Partners
MDGL icon

Artisan Partners’s Madrigal Pharmaceuticals MDGL Stock Holding History

Artisan Partners’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113M Buy
210,205
+26,665
+15% +$13.7M 0.18% 118
2026
Q1 		$96.1M Sell
183,540
-15,153
-8% -$7.24M 0.15% 137
2025
Q4 		$116M Sell
198,693
-7,561
-4% -$3.86M 0.17% 139
2025
Q3 		$94.6M Buy
206,254
+4,683
+2% +$1.75M 0.13% 150
2025
Q2 		$61M Buy
201,571
+63,833
+46% +$19M 0.09% 192
2025
Q1 		$45.6M Sell
137,738
-69,731
-34% -$22.9M 0.07% 223
2024
Q4 		$64M Sell
207,469
-99,377
-32% -$28M 0.1% 207
2024
Q3 		$65.1M Sell
306,846
-38,239
-11% -$9.78M 0.1% 192
2024
Q2 		$96.7M Sell
345,085
-56,624
-14% -$13.5M 0.15% 150
2024
Q1 		$107M Buy
401,709
+105,229
+35% +$24.8M 0.16% 137
2023
Q4 		$68.6M Buy
296,480
+16,390
+6% +$2.87M 0.11% 185
2023
Q3 		$40.9M Buy
280,090
+50,000
+22% +$9.41M 0.07% 219
2023
Q2 		$53.2M Buy
230,090
+14,320
+7% +$3.88M 0.09% 205
2023
Q1 		$52.3M Buy
215,770
+3,480
+2% +$948K 0.09% 213
2022
Q4 		$61.6M Buy
212,290
+1,808
+0.9% +$177K 0.11% 183
2022
Q3 		$13.7M Sell
210,482
-1,237
-0.6% -$85.9K 0.02% 272
2022
Q2 		$15.2M Sell
211,719
-12,097
-5% -$889K 0.03% 268
2022
Q1 		$22M Buy
223,816
+3,932
+2% +$332K 0.03% 282
2021
Q4 		$18.6M Sell
219,884
-1,005
-0.5% -$82.6K 0.02% 302
2021
Q3 		$17.6M Buy
220,889
+202
+0.1% +$17.4K 0.02% 294
2021
Q2 		$21.5M Buy
220,687
+6,262
+3% +$741K 0.03% 292
2021
Q1 		$25.1M Buy
214,425
+4,045
+2% +$472K 0.03% 299
2020
Q4 		$23.4M Buy
210,380
+37,120
+21% +$4.54M 0.03% 293
2020
Q3 		$20.6M Buy
+173,260
New +$18.8M 0.03% 286

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners's MDGL Position: Q2 2026 in Review

Artisan Partners increased its Madrigal Pharmaceuticals (MDGL) stake by 15% in Q2 2026, buying an estimated $13.7M and bringing the position to 210,205 shares worth $113M. The position accounts for 0.18% of the portfolio, ranked #118.

Artisan Partners first reported a position in MDGL in Q3 2020 and has held it in 24 quarters since. The position peaked at $116M in Q4 2025. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Artisan Partners held 210,205 shares of Madrigal Pharmaceuticals worth $113M as of Q2 2026.
  • Artisan Partners bought 26,665 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $13.7M.
  • Madrigal Pharmaceuticals made up 0.18% of Artisan Partners's portfolio in Q2 2026, its #118 holding.
  • Artisan Partners first reported a position in Madrigal Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • Artisan Partners's Madrigal Pharmaceuticals position peaked at $116M in Q4 2025.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Artisan Partners's 13F filing for Q2 2026, filed 13 Aug 2026.